Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.12530/87446
Full metadata record
DC FieldValueLanguage
dc.contributor.authorEstremera-Arevalo, Fermin
dc.contributor.authorBarcelo, Marta
dc.contributor.authorSerrano, Blanca
dc.contributor.authorRey, Enrique
dc.date.accessioned2023-04-17T07:51:23Z-
dc.date.available2023-04-17T07:51:23Z-
dc.date.issued2019
dc.identifier.citationWorld J Gastroenterol.2019;(25)7:837-847
dc.identifier.urihttps://hdl.handle.net/20.500.12530/87446-
dc.description.abstractIrritable bowel syndrome (IBS) is a highly prevalent condition. It is diagnosed on the basis of chronic symptoms after the clinical and/or investigative exclusion of organic diseases that can cause similar symptoms. There is no reproducible non-invasive test for the diagnosis of IBS, and this raises diagnostic uncertainty among physicians and hinders acceptance of the diagnosis by patients. Functional gastrointestinal (GI) syndromes often present with overlapping upper and lower GI tract symptoms, now believed to be generated by visceral hypersensitivity. This study examines the possibility that, in IBS, a nutrient drink test (NDT) provokes GI symptoms that allow a positive differentiation of these patients from healthy subjects. To evaluate the NDT for the diagnosis of IBS. This prospective case-control study compared the effect of two different nutrient drinks on GI symptoms in 10 IBS patients (patients) and 10 healthy controls (controls). The 500 kcal high nutrient drink and the low nutrient 250 kcal drink were given in randomized order on separate days. Symptoms were assessed just before and at several time points after drink ingestion. Global dyspepsia and abdominal scores were derived from individual symptom data recorded by two questionnaires designed by our group, the upper and the general GI symptom questionnaires, respectively. Psycho-social morbidity and quality of life were also formally assessed. The scores of patients and controls were compared using single factor analysis of variance test. At baseline, IBS patients compared to controls had significantly higher levels of GI symptoms such as gastro-esophageal reflux (P = 0.05), abdominal pain (P = 0.001), dyspepsia (P = 0.001), diarrhea (P = 0.001), and constipation (P = 0.001) as well as higher psycho-social morbidity and lower quality of life. The very low incidence of GI symptoms reported by control subjects did not differ significantly for the two test drinks. Compared with the low nutrient drink, IBS patients with the high nutrient drink had significantly more dyspeptic symptoms at 30 (P = 0.014), 45 (P = 0.002), 60 (P = 0.001), and 120 min (P = 0.011). Dyspeptic symptoms triggered by the high nutrient drink during the first 120 min gave the best differentiation between healthy controls and patients (area under receiver operating curve of 0.915 at 45 min for the dyspepsia score). Continued symptom monitoring for 24 h did not enhance separation of patients from controls. A high NDT merits further evaluation as a diagnostic tool for IBS.
dc.language.isoen
dc.rightsopenAccess
dc.rights.urihttp://creativecommons.org/licenses/by-nc/3.0/es/
dc.subjectDyspepsia
dc.subjectIrritable bowel syndrome
dc.subjectNon-invasive
dc.subjectNutrient drink test
dc.subjectScreening
dc.subject.meshAbdominal Pain
dc.subject.meshBeverages
dc.subject.meshCase-Control Studies
dc.subject.meshDiagnosis, Differential
dc.subject.meshDietary Sucrose
dc.subject.meshDyspepsia
dc.subject.meshFemale
dc.subject.meshFood, Formulated
dc.subject.meshHealthy Volunteers
dc.subject.meshHumans
dc.subject.meshIrritable Bowel Syndrome
dc.subject.meshMale
dc.subject.meshProspective Studies
dc.subject.meshQuality of Life
dc.titleNutrient drink test: A promising new tool for irritable bowel syndrome diagnosis.
dc.typeArtículo
dc.identifier.pubmedID30809083
dc.format.volume25
dc.format.page837-847
dc.identifier.e-issn2219-2840
dc.identifier.journalWorld journal of gastroenterology
dc.identifier.journalabbreviationWorld J Gastroenterol
dc.identifier.doi10.3748/wjg.v25.i7.837
dc.format.number7
dc.identifier.pmcPMC6385016
dc.pubmedtypeComparative Study
dc.pubmedtypeJournal Article
dc.pubmedtypeRandomized Controlled Trial
dc.identifier.pubmedURLhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6385016/pdf
Appears in Collections:Hospitales > H. U. Infanta Leonor > Artículos
Hospitales > H. U. Clínico San Carlos > Artículos
Fundaciones e Institutos de Investigación > IIS H. U. Clínico San Carlos > Artículos

Files in This Item:
File SizeFormat 
PMC6385016.pdf1.45 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons